Phase 2 Pemphigus Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Pemphigus Vulgaris
Cabaletta Bio40 enrolled13 locationsNCT04422912
Recruiting
Phase 2Phase 3
A Clinical Study of B007 in the Treatment of Pemphigus.
Pemphigus
Shanghai Jiaolian Drug Research and Development Co., Ltd132 enrolled12 locationsNCT06454357